Inventor
NOZAKI CHIKATERU
JP33 patents
⚠️ This page may combine multiple inventors who share the name “NOZAKI CHIKATERU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHEMO SERO THERAPEUT RES INST
17 patentsUS5024938AJun 18, 1991
Recombinant DNA inserted with hepatitis B virus gene, mammalian cells transformed with cloned viral DNA, and production of hepatitis B virus proteins
CHEMO SERO THERAPEUT RES INST55 citations95
US4997767AMar 5, 1991
Yeast shuttle vector
CHEMO SERO THERAPEUT RES INST34 citations92
US7112666B2Sep 26, 2006
Von Willebrand Factor (Vwf)-cleaving protease
CHEMO SERO THERAPEUT RES INST24 citations91
US4778761AOct 18, 1988
Recombinant plasmid inserted with hepatitis B virus gene, yeast transformed with said recombinant plasmid, and production of hepatitis B virus surface antigen
CHEMO SERO THERAPEUT RES INST42 citations90
US7575872B2Aug 18, 2009
Antibody against von Willebrand factor cleaving enzyme and assay system using the same
CHEMO SERO THERAPEUT RES INST15 citations82
US7361748B2Apr 22, 2008
von Willebrand factor (vWF)—cleaving protease
CHEMO SERO THERAPEUT RES INST11 citations82
US7199097B1Apr 3, 2007
Peptide fragments having cell death inhibitory activity
CHEMO SERO THERAPEUT RES INST7 citations73
US7704951B2Apr 27, 2010
Method for ameliorating dyskinesia
CHEMO SERO THERAPEUT RES INST7 citations71
US5059538AOct 22, 1991
Recombinant plasmid inserted with herpes simplex virus gene
CHEMO SERO THERAPEUT RES INST17 citations71
US5811260ASep 22, 1998
Exogenous gene expression vector containing chick β-actin gene promoter
CHEMO SERO THERAPEUT RES INST9 citations70
US5770400AJun 23, 1998
Exogenous gene expression vector containing chick β-actin gene promoter
CHEMO SERO THERAPEUT RES INST7 citations70
US4612283ASep 16, 1986
Method for purification of HBs antigen
CHEMO SERO THERAPEUT RES INST8 citations69
US8940306B2Jan 27, 2015
Method for enhancing immune response with peptide
CHEMO SERO THERAPEUT RES INST0 citations51
US7960508B2Jun 14, 2011
Peptide having cytotoxicity inhibitory activity and method of screening these peptide having cytotoxicity inhibitory activity
CHEMO SERO THERAPEUT RES INST1 citations51
US7598349B2Oct 6, 2009
Antibodies to peptide fragments having cell death-inhibitory activity
CHEMO SERO THERAPEUT RES INST0 citations51
US8043629B2Oct 25, 2011
Bioabsorbable synthetic nonwoven fabric holding thrombin
CHEMO SERO THERAPEUT RES INST1 citations50
US7635577B2Dec 22, 2009
Process for producing human thrombin by gene modification technique
CHEMO SERO THERAPEUT RES INST0 citations47
ISIS PHARMACEUTICALS INC
6 patentsUS6174868B1Jan 16, 2001
Compositions and methods for treatment of hepatitis C virus-associated diseases
ISIS PHARMACEUTICALS INC141 citations98
US6423489B1Jul 23, 2002
Compositions and methods for treatment of Hepatitis C virus-associated diseases
ISIS PHARMACEUTICALS INC120 citations96
US6391542B1May 21, 2002
Compositions and methods for treatment of Hepatitis C virus-associated diseases
ISIS PHARMACEUTICALS INC95 citations96
US6284458B1Sep 4, 2001
Compositions and methods for treatment of hepatitis C virus-associated diseases
ISIS PHARMACEUTICALS INC87 citations96
US6608191B1Aug 19, 2003
Compositions and methods for treatment of hepatitis C virus-associated diseases
ISIS PHARMACEUTICALS INC34 citations92
US6995146B2Feb 7, 2006
Compositions and methods for treatment of hepatitis C virus-associated diseases
ISIS PHARMACEUTICALS INC26 citations88